Status:
COMPLETED
Severe PID With Lymphoproliferation and Neutropenia
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to analyse the phenotype in a sub-population of adults with severe primary immunodeficiency with lymphoproliferation and neutropenia and to decipher the possible pathways ...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- \>18 years old
- CVID (Common Variable Immunodeficiency)
- Neutropenia
- Lymphoproliferation
- Exclusion Criteria :
- \- Secondary immunodeficiency
Exclusion
Key Trial Info
Start Date :
March 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2019
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT03427593
Start Date
March 13 2018
End Date
December 5 2019
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Immunologie Clinique et VIH - Hôpital Civil
Strasbourg, France, 67091